Pharmaceutical Crystals (Volume II)

The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential...

Full description

Saved in:
Bibliographic Details
Other Authors: Yonemochi, Etsuo (Editor), Uekusa, Hidehiro (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_98034
005 20230307
003 oapen
006 m o d
007 cr|mn|---annan
008 20230307s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-5474-7 
020 |a 9783036554730 
020 |a 9783036554747 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-5474-7  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a TB  |2 bicssc 
072 7 |a TQ  |2 bicssc 
100 1 |a Yonemochi, Etsuo  |4 edt 
700 1 |a Uekusa, Hidehiro  |4 edt 
700 1 |a Yonemochi, Etsuo  |4 oth 
700 1 |a Uekusa, Hidehiro  |4 oth 
245 1 0 |a Pharmaceutical Crystals (Volume II) 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (176 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The crystalline state is the most commonly used as an essential solid in active pharmaceutical ingredients (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines. Still, the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. These properties should be understood in terms of molecular structures and interactions between molecules in crystals. Information on three-dimensional molecular structures also affords insights into the biological activity of molecules. The second reprint in the series, "Crystalline Pharmaceuticals (Volume II)" focused on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts and hydrates, and polymorph crystals, were reported with interest. Such crystal structures contributed to the latest studies that combine morphology, spectroscopic, theoretical calculation, and thermal analysis with the crystallographic study. Thus, this reprint highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure-property study of pharmaceutical crystals. The Guest Editors of this reprint hope the readers enjoy a wide variety of recent studies on "Crystalline Pharmaceuticals." 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Technology: general issues  |2 bicssc 
650 7 |a Environmental science, engineering & technology  |2 bicssc 
653 |a anastrozole 
653 |a non-covalent interactions 
653 |a halogen bonding 
653 |a lp-π interactions 
653 |a DFT 
653 |a QTAIM 
653 |a synthesis 
653 |a crystal structure 
653 |a fenclorim 
653 |a antifungal activity 
653 |a pyrimidine 
653 |a enrofloxacin 
653 |a salts 
653 |a organic acids 
653 |a solubility 
653 |a methimazole 
653 |a 1,2-bis[(1-methyl-1H-imidazole-2-yl)thio]ethane 
653 |a solid-state forms 
653 |a hydrates 
653 |a dehydration 
653 |a disordered crystal structure 
653 |a hydrogen bonding 
653 |a in silico docking 
653 |a Hirshfeld surface 
653 |a NF-κB signaling 
653 |a IKKβ inhibitor 
653 |a venetoclax 
653 |a crystals 
653 |a hydrate 
653 |a conformation 
653 |a X-ray diffraction 
653 |a nanocrystalline materials 
653 |a physicochemical characterization 
653 |a vibrational spectroscopy 
653 |a X-ray analysis 
653 |a thermal analysis 
653 |a critical quality attributes 
653 |a Disopyramide 
653 |a Terephthalic acid 
653 |a salt 
653 |a molecular packing 
653 |a slurry crystallization 
653 |a disopyramide 
653 |a phthalic acid 
653 |a metastable 
653 |a crystal structure analysis 
653 |a diclofenac 
653 |a diclofenac sodium 
653 |a hydration-dehydration mechanism 
653 |a anhydrate 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6761  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/98034  |7 0  |z DOAB: description of the publication